Acne Vulgaris Market Report 2024 (Global Edition)

Global Acne Vulgaris Market Report 2024 Market Size Split by Type Outlook: (Systemic Therapy, Harmonal Therapy, Physical Treatment, Topical Combination Therapy, Others), by Application Outlook:{apllic...

Acne Vulgaris Market Report Description

We have various report editions of Acne Vulgaris Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Acne Vulgaris Market

The competitive context of the acne vulgaris industry offers information broken down by competition. In-depth information is provided about the business's background, finances, earnings, prospective markets, R&D spending, emerging market efforts, international manufacturing locations and infrastructure, manufacturing capabilities, company advantages and disadvantages, introduction of products, goods length and dimension, and sector superiority. The earlier statistics only pertain to the companies' concentration on the acne vulgaris industry.

In May 2024, Cosmo Pharmaceuticals revealed that the next version of gastrointestinal Smart hardware, the most recent iteration of the GI Smart digital gastroenterology structure, which Medtronic exclusively sells worldwide, has received 510(k) clearance from the USA's Food and Drug Administration (FDA). The achievement represents a major development in healthcare equipment and underlines the GI Genius platform's superiority in AI-enhanced procedures. (Source: https://www.cosmopharma.com/news/cosmo-intelligent-medical-devices-unveils-next-generation-gi-genius-hardware-with-new-fda-clearance) In February 2024, Bausch Health Companies Inc. and its digestive health (GI) division, Salix Pharmaceuticals ("Salix"), released the Liver Health Trends Provide in Activity, the most recent Liver Health Annual Developments Reporting. In order to detect at-risk patients earlier and avoid difficulties from serious liver disorders in the future, medical professional respondents advocated for comprehensive, multimodal therapies, frequent utilization of harmless screening techniques, and enhanced instruction. (Source: https://ir.bauschhealth.com/news-releases/2024/10-08-2024) In January 2024, AOBiome Therapeutics Inc. ("AOB"), which focuses on diseases caused by inflammation, declared that it has signed a sole license and manufacturing contract with Maruho Co., Ltd. to develop and market AOB's external biologic B244, as a medical device for dermatological evidence such as Atopic Dermatitis, that includes both appearances and pruritus (itch). The authorization applies to all indicators that the B244 architecture accepts. (Source: https://www.aobiome.com/pressreleases/aob-pharma-and-maruho-enter-into-an-exclusive-license-agreement-for-aob-pharmas-topical-biologic-b244-for-the-treatment-of-inflammatory-indications-including-atopic-dermatitis-in-japan/#primary)

Top Companies Market Share in Acne Vulgaris Industry: (In no particular order of Rank)

• Ortho Dermatologics
• Galderma/Mayne Pharma
• Almirall S.A./Paratek Pharmaceuticals
• Stiefel Laboratories
• Cosmo Pharmaceuticals
• Bausch Health Companies
• Novan
• AOBiome llc
• Botanix Pharmaceuticals
• AndroScience Corporation
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Acne Vulgaris Market

Which Region Dominates the Acne Vulgaris Market in 2024?

According to Cognitive Market Research, North America currently dominates the acne vulgaris market, and the region is expected to have significant growth during the projected period. This is due to the rising prevalence of acne in the area and the rise in consumer issues pertaining to appearance. Additionally, a significant increase in the number of patients and the introduction of new products by significant regional companies would accelerate the market's growth.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR) because of the growing number of patients in the area and the expanding amount of money being spent on medical dermatology advancements and research. The industry will be driven by the growing use of innovative therapies and remedies..

The current report Scope analyzes Acne Vulgaris Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Acne Vulgaris

According to Cognitive Market Research, the global acne vulgaris market size was estimated at USD 7124.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 2849.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the acne vulgaris market with a market size of USD 2248.40 million in 2024 and is projected to grow at a CAGR of 2.0% during the forecast period. The U.S. market's Stringent governmental regulations.
• The Canada acne vulgaris market had a market share of USD 341.96 million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. Canada’s rising awareness among the population.
• The Mexico acne vulgaris market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 259.32 million in 2024.

Europe Acne Vulgaris

According to Cognitive Market Research, the global acne vulgaris market size was estimated at USD 7124.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 2137.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.5% from 2024 to 2031.

• The United Kingdom acne vulgaris market had a market share of USD 359.06 million in 2024 and is projected to grow at a CAGR of 3.3% during the forecast period. In the UK, acne vulgaris sales witness an upswing due to the nation's rising demand for innovative technology.
• The France acne vulgaris market is projected to witness growth at a CAGR of 1.7% during the forecast period, with a market size of USD 196.63 million in 2024.
• According to Cognitive Market Research, the German acne vulgaris market size was valued at USD 423.18 million in 2024 and is projected to grow at a CAGR of 2.7% during the forecast period. In Germany, acne vulgaris surged due to the presence of major market players.
• The Italy acne vulgaris market is projected to witness growth at a CAGR of 1.9% during the forecast period, with a market size of USD 183.80 million in 2024.
• The Russia acne vulgaris market is projected to witness growth at a CAGR of 1.5% during the forecast period, with a market size of USD 331.28 million in 2024.
• The Spain acne vulgaris market is projected to witness growth at a CAGR of 1.6% during the forecast period with a market size of USD 175.26 million in 2024
• The Luxembourg acne vulgaris market is projected to witness growth at a CAGR of 2.6% during the forecast period, with a market size of USD 66.26 million in 2024.
• The Portugal acne vulgaris market is projected to witness growth at a CAGR of 2.3% during the forecast period, with a market size of USD 44.88 million in 2024.
• The Greece acne vulgaris market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 25.65 million in 2024.
• The Rest of Europe's acne vulgaris market is projected to witness growth at a CAGR of 1.2% during the forecast period, with a market size of USD 331.28 million in 2024.

Asia Pacific Acne Vulgaris

According to Cognitive Market Research, the global acne vulgaris market size was estimated at USD 7124.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 1638.57 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.0% from 2024 to 2031.

• According to Cognitive Market Research, the China acne vulgaris market size was valued at USD 737.35 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. Acne vulgaris surged in China due to Increased focus of the manufacturers and major market players.
• The Japan acne vulgaris market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 226.12 million in 2024.
• The India acne vulgaris market had a market share of USD 196.63 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period. India's rising awareness among the populations.
• The South Korean acne vulgaris market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 163.86 million in 2024.
• The Australian acne vulgaris market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 85.21 million in 2024.
• The South East Asia acne vulgaris market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 113.06 million in 2024.
• The Rest of Asia Pacific acne vulgaris market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 116.34 million in 2024.

South America Acne Vulgaris

According to Cognitive Market Research, the global acne vulgaris market size was estimated at USD 7124.2 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 356.21 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil acne vulgaris market size was valued at USD 152.46 million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. Acne vulgaris flourished in Brazil due to increasing demand for packaged food and beverages.
• Argentina's acne vulgaris market had a market share of USD 59.84 million in 2024 and is projected to grow at a CAGR of 4.3% during the forecast period. Argentina's rising personal disposable income .
• Colombia acne vulgaris market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 31.70 million in 2024.
• Peru acne vulgaris market is projected to witness growth at a CAGR of 3.6% during the forecast period, with a market size of USD 29.21 million in 2024.
• Chile acne vulgaris market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 25.65 million in 2024.
• The Rest of Latin America's acne vulgaris market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 57.35 million in 2024.

Middle East and Africa Acne Vulgaris

According to Cognitive Market Research, the global acne vulgaris market size was estimated at USD 7124.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 142.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031..

• The GCC Countries acne vulgaris market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 60.98 million in 2024. Acne vulgaris sales flourish due to the presence of major market players.
• The Egypt acne vulgaris market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 14.96 million in 2024.
• The South Africa acne vulgaris market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 22.51 million in 2024. Acne vulgaris sales flourished in South Africa due to increasing demand and regulatory support.
• The Turkey acne vulgaris market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 12.25 million in 2024.
• The Nigeria acne vulgaris market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 14.96 million in 2024.
• The Rest of the MEA acne vulgaris market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 16.81 million in 2024.

Acne Vulgaris Market Analysis

How are Segments Performing in the Global Acne Vulgaris Market?

Acne Vulgaris Market Type Segment Analysis

According to Cognitive Market Research, topical combination therapy is likely to dominate the acne vulgaris market over the forecast period. The increase can be attributed to the growing number of businesses producing topical acne treatment products. This is explained by the fact that patients with the illness are mainly drawn to topical treatments since they are easy to use and convenient.

The systemic therapy is the fastest-growing segment in the acne vulgaris market. Because through systemic treatment, people can enhance their interaction and forge closer bonds with one another. Positive interactions require that people have sensitivity for others, which systemic treatment can help individuals acquire. People of different generations and socioeconomic statuses, especially those who suffer from psychological issues, especially mood disorders and anxiety, can benefit from systemic therapy.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Acne Vulgaris Industry. Request a Free Sample PDF!

Acne Vulgaris Market Application Segment Analysis

According to Cognitive Market Research, the hospital segment holds the largest market share. This is because fertility rates have increased in emerging economies, individuals are becoming more aware of skin treatment tools, and self-skin care items are becoming more widely used.

In the acne vulgaris market, the rapidly growing sector is the others. Because of the growing number of organizations and online resources that provide acne treatment products. In addition to providing medical care, medical professionals offer their patients lifestyle, physical activity, and prescription advice. Early detection and treatment are provided even to persistently sick people.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion